The new combination product of pertuzumab with trastuzumab together with hyaluronidase (Phesgo, Roche), which can be administered by subcutaneous injection, has been recommended for approval in the ...
Positive recommendation based on clinical, real-world and bioequivalence data supporting feasibility and safety of Phesgo’s administration outside of clinical settings, for example at home1-4 Phesgo ...
KORU Medical Systems, Inc.KRMD recently announced that it has submitted a 510(k) premarket notification for FDA clearance to use its FreedomEDGE infusion system to deliver PHESGO, a breast cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results